{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T17:15:22Z","timestamp":1764782122981,"version":"3.37.3"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.pbb.2017.09.002","type":"journal-article","created":{"date-parts":[[2017,9,6]],"date-time":"2017-09-06T21:49:42Z","timestamp":1504734582000},"page":"22-29","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Prediction of human efficacious antidepressant doses using the mouse forced swim test"],"prefix":"10.1016","volume":"161","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2145-6368","authenticated-orcid":false,"given":"Eunice","family":"Yuen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Swanson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey M.","family":"Witkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"author":"GlaxoSmithKline","key":"10.1016\/j.pbb.2017.09.002_bb0005"},{"key":"10.1016\/j.pbb.2017.09.002_bb0010","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1146\/annurev-med-053013-062946","article-title":"Ketamine and rapid-acting antidepressants: a window into a new neurobiology for mood disorder therapeutics","volume":"66","author":"Abdallah","year":"2015","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.pbb.2017.09.002_bb0015","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1590\/1516-4446-2013-1098","article-title":"Animal models as tools to study the pathophysiology of depression","volume":"35","author":"Abelaira","year":"2013","journal-title":"Rev. Bras. Psiquiatr."},{"year":"1989","series-title":"NONMEM User's Guides","author":"Beal","key":"10.1016\/j.pbb.2017.09.002_bb0020"},{"key":"10.1016\/j.pbb.2017.09.002_bb0025","doi-asserted-by":"crossref","first-page":"147-60","DOI":"10.1007\/BF00176837","article-title":"Is the forced swimming test a suitable model for revealing antidepressant activity?","volume":"94","author":"Borsini","year":"1988","journal-title":"Psychopharmacologia"},{"key":"10.1016\/j.pbb.2017.09.002_bb0030","first-page":"1","article-title":"Antidepressant effects of ketamine: mechanisms underlying fast-acting novel antidepressants","volume":"4","author":"Browne","year":"2013","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.pbb.2017.09.002_bb0035","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2165\/00003088-199834040-00002","article-title":"Metabolism of the newer antidepressants: an overview of the pharmacological and pharmacokinetic implications","volume":"34","author":"Caccia","year":"1998","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.pbb.2017.09.002_bb0040","doi-asserted-by":"crossref","first-page":"238-45","DOI":"10.1016\/S0165-6147(02)02017-5","article-title":"Assessing antidepressant activity in rodents: recent developments and future needs","volume":"23","author":"Cryan","year":"2002","journal-title":"Trends Pharmacol. Sci."},{"author":"Drugs.com [citalopram]","key":"10.1016\/j.pbb.2017.09.002_bb0045"},{"author":"Drugs.com [desipramine]","key":"10.1016\/j.pbb.2017.09.002_bb0050"},{"author":"Drugs.com [desvenlafaxine]","key":"10.1016\/j.pbb.2017.09.002_bb0055"},{"key":"10.1016\/j.pbb.2017.09.002_bb0065","series-title":"The Population Pharmacokinetics of Citalopram After Deliberate Self-poisoning: A Bayesian Approach","first-page":"571","volume":"32","author":"Friberg","year":"2005"},{"author":"Johnson & Johnson","key":"10.1016\/j.pbb.2017.09.002_bb0070"},{"key":"10.1016\/j.pbb.2017.09.002_bb0080","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/bmc.1367","article-title":"Dried blood spot sampling in combination with LC-MS\/MS for quantitative analysis of small molecules","volume":"24","author":"Li","year":"2010","journal-title":"Biomed. Chromatogr."},{"issue":"1","key":"10.1016\/j.pbb.2017.09.002_bb0085","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1124\/jpet.106.103143","article-title":"MGlu5 receptor antagonism is associated with antidepressant-like effects in mice","volume":"319","author":"Li","year":"2006","journal-title":"J. Pharmacol. & Exp. Ther."},{"key":"10.1016\/j.pbb.2017.09.002_bb0090","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/00008877-199711000-00010","article-title":"The forced swimming test as a model for core and component behavioural effects of antidepressant drugs","volume":"8","author":"Lucki","year":"1997","journal-title":"Behav. Pharmacol."},{"issue":"8","key":"10.1016\/j.pbb.2017.09.002_bb0095","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1017\/S1461145711001945","article-title":"Serotonin transporter occupancy with TCAs and SSRIs: a PET study in patients with major depressive disorder","volume":"15","author":"Lundberg","year":"2012","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.pbb.2017.09.002_bb0100","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00213-004-2048-7","article-title":"Forced swimming test in mice: a review of antidepressant activity","volume":"177","author":"Petit-Demouliere","year":"2005","journal-title":"Psychopharmacologia"},{"key":"10.1016\/j.pbb.2017.09.002_bb0105","first-page":"327","article-title":"Behavioural despair in mice: a primary screening test for antidepressants","volume":"229","author":"Porsolt","year":"1977","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"key":"10.1016\/j.pbb.2017.09.002_bb0110","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/266730a0","article-title":"Depression: a new animal model sensitive to antidepressant treatments","volume":"266","author":"Porsolt","year":"1977","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.pbb.2017.09.002_bb0115","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1038\/npp.2015.348","article-title":"A selective nociceptin receptor antagonist to treat depression: evidence from preclinical and clinical studies","volume":"41","author":"Post","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2017.09.002_bb0120","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1002\/chir.20452","article-title":"Enantioselective analysis of citalopram and demethylcitalopram in human and rat plasma by chiral LC-MS\/MS: application to pharmacokinetics","volume":"19","author":"Rocha","year":"2007","journal-title":"Chirality"},{"key":"10.1016\/j.pbb.2017.09.002_bb0125","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.biopsych.2012.05.003","article-title":"Ketamine for depression: where do we go from here?","volume":"72","author":"Rot","year":"2012","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pbb.2017.09.002_bb0130","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1176\/ajp.2006.163.11.1905","article-title":"Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report","volume":"163","author":"Rush","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pbb.2017.09.002_bb0135","doi-asserted-by":"crossref","first-page":"346","DOI":"10.2165\/00003088-199018050-00002","article-title":"Clinical pharmacokinetics of imipramine and desipramine","volume":"18","author":"Salle","year":"1990","journal-title":"Clin. Pharmacokinet."},{"issue":"6","key":"10.1016\/j.pbb.2017.09.002_bb0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0179927","article-title":"Estimation of the optimal dosing regimen of escitalopram in dogs: a dose occupancy study with [11C]DASB","volume":"12","author":"Taylor","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.pbb.2017.09.002_bb0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0014-2999(90)90204-J","article-title":"Functional antagonists at the NMDA receptor complex exhibit antidepressant actions","volume":"185","author":"Trullas","year":"1990","journal-title":"Eur. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.pbb.2017.09.002_bb0150","doi-asserted-by":"crossref","first-page":"721-33","DOI":"10.1007\/s10928-015-9448-7","article-title":"A population PK model for citalopram and its major metabolite, N-desmethyl citalopram, in rats","volume":"42","author":"Velez de Mendizabal","year":"2015","journal-title":"J. Pharmacokinet. Pharmacodyn."},{"issue":"3","key":"10.1016\/j.pbb.2017.09.002_bb0155","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3109\/00498258709043939","article-title":"Pharmacological significance of the species differences in bupropion metabolism","volume":"17","author":"Welch","year":"1987","journal-title":"Xenobiotica"},{"key":"10.1016\/j.pbb.2017.09.002_bb0160","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.neuropharm.2008.01.001","article-title":"Predictive validity of animal pain models? A comparison of the pharmacokinetic-pharmacodynamic relationship for pain drugs in rats and humans","volume":"54","author":"Whiteside","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2017.09.002_bb0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00427414","article-title":"The validity of animal models of depression","volume":"83","author":"Willner","year":"1984","journal-title":"Psychopharmacologia"},{"key":"10.1016\/j.pbb.2017.09.002_bb0170","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.seizure.2014.11.006","article-title":"Can pentylenetetrazole and maximal electroshock rodent seizure models quantitatively predict antiepileptic efficacy in humans?","volume":"24","author":"Yuen","year":"2015","journal-title":"Seizure"},{"key":"10.1016\/j.pbb.2017.09.002_bb0175","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature17998","article-title":"NMDAR inhibition-independent antidepressant actions of ketamine metabolites","volume":"533","author":"Zanos","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.pbb.2017.09.002_bb0180","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.1365-2125.2012.04198.x","article-title":"Simultaneous population pharmacokinetic modelling of ketamine and three major metabolites in patients with treatment-resistant bipolar depression","volume":"74","author":"Zhao","year":"2012","journal-title":"Br. J. Clin. Pharmacol."}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305717304331?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305717304331?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,5,12]],"date-time":"2021-05-12T14:19:37Z","timestamp":1620829177000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091305717304331"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":34,"alternative-id":["S0091305717304331"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2017.09.002","relation":{},"ISSN":["0091-3057"],"issn-type":[{"type":"print","value":"0091-3057"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prediction of human efficacious antidepressant doses using the mouse forced swim test","name":"articletitle","label":"Article Title"},{"value":"Pharmacology Biochemistry and Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pbb.2017.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}